PA-TU-8988T

Cat.No.: CSC-C0307

Species: Homo sapiens (Human)

Source: Liver Metastasis

Morphology: adherent cells growing in monolayers

Culture Properties: monolayer

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C0307
Description
Established in 1985 from the liver metastasis of a primary pancreatic adenocarcinoma from a 64-year-old woman; sister cell line of PA-TU-8988S
Species
Homo sapiens (Human)
Source
Liver Metastasis
Recommended Medium
Culture Properties
monolayer
Morphology
adherent cells growing in monolayers
Karyotype
Human near-triploid karyotype with 2% polyploidy - 68(63-70)<3n>XXX, -4, +6, +6, +8, +11, -15, -16, -17, -19, +20, -21, -22, +mar, der(1)t(1;?)(p11;?), i(6p), del(6)(q23)x2, der(8)t(8;?)(q24.3;?), der(8)t(8;?)(p11;?)x2, der(11)t(11;?)(p13;?)x2, del(12)(p1
Disease
Pancreatic Adenocarcinoma
Quality Control
Mycoplasma: negative in DAPI, microbiological culture, RNA hybridization, PCR assays
Immunology: cytokeratin +, cytokeratin-7 -, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 -, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -,
Storage and Shipping
Frozen with 70% medium, 20% FBS, 10% DMSO at about 2 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Synonyms
PaTu 8988t; PaTu8988t; PaTu8988T; PATU8988T; PaTu 8988 T; PaTu-8988t; PATU-8988T; PATU-T; PA-TU T; 8988T; PaCL4
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

PA-TU-8988T (also designated PaTu 8988t) is a human pancreatic ductal adenocarcinoma cell line established in 1985 from a liver metastasis of a primary pancreatic adenocarcinoma in a 64‑year‑old female patient. It is the poorly differentiated, highly tumorigenic sister line of PA‑TU‑8988S, with both originating from the same metastatic deposit. The line carries driver mutations in KRAS, SMAD4, and TP53, a near‑triploid karyotype (63‑70 chromosomes) and is microsatellite‑stable.

The primary advantage of PA‑TU‑8988T lies in its syngeneic relationship with PA‑TU‑8988S. Despite sharing the same genetic background, the two exhibit sharply contrasting phenotypes: PA‑TU‑8988T forms highly polarized tubular structures in xenografts, expresses abundant mucin, and shows markedly higher transglutaminase activity, indicative of greater differentiation. Most strikingly, PA‑TU‑8988S readily colonizes the lung after intravenous injection, whereas PA‑TU‑8988T fails to metastasize. These lines thus constitute an isogenic model uniquely suited to dissect the molecular underpinnings of differentiation and metastatic competence.

This isogenic pair has been extensively utilized to explore differential glycosylation patterns, galectin‑4‑mediated metastasis restriction, and transcriptional programs controlling autophagy‑lysosome function. PA‑TU‑8988T has also enabled functional validation of stress‑induced apoptosis pathways (e.g., via DDOST or NOX4 manipulation) and drug sensitivity evaluations, advancing studies of pancreatic cancer biology, biomarker discovery, and therapeutic targeting.

Chamber Gap Assay for Studying Pancreatic Cancer-Induced Macrophage Recruitment and Morphological Alteration

Pancreatic cancer is characterized by an immunosuppressive tumor environment in which macrophages are recruited and reprogrammed to support tumor growth. Studying macrophage migration and polarization is crucial for understanding disease progression and identifying therapeutic targets. However, existing in vitro methods such as the transwell assay provide limited spatial resolution and do not allow visualization of cell movement or morphological changes. Here, Lenz, Maik established and evaluated the Chamber Gap Assay (CGA), a modified two-compartment culture system that enables direct, time-resolved observation and quantification of macrophage migration toward pancreatic cancer cells as well as phenotypic alterations.

Using murine and human macrophage-cancer cell models, we compared the performance of the CGA with the transwell assay. We found that macrophage monocultures displayed substantial spontaneous migration in the transwell system, while cancer cells induced only modest additional macrophage recruitment. In contrast, the CGA demonstrated clear and highly significant directional macrophage movement toward cancer cells, with distinct migration patterns and improved sensitivity for detecting group differences. The method also enabled visualization of cancer cell movement within the same system. Furthermore, CGA offers observations of morphological changes in immune cells under the influence of pancreatic cancer cells.

These findings indicate that the CGA provides a robust and physiologically relevant method for studying tumor-induced immune cell recruitment and associated morphological changes.

The effects of the human pancreatic cancer cell lines PA-TU-8988T and PA-TU-8988S on the migration of THP-1 macrophages.

Fig. 1. Microscopic pictures of migrated THP-1 cells and quantification of migration in CGA (Lenz, Maik, et al., 2026).

Chamber Gap Assay enabled visualization of cancer cell and macrophage migration.

Fig. 2. Visualization of cancer cell and macrophage migration in the Chamber Gap Assay (Lenz, Maik, et al., 2026).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products